Squarepoint
OSIR

Squarepoint’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Squarepoint’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29,620
Closed -$563K – 2850
2019
Q1 		$563K Buy
+29,620
New +$480K 0.01% 1423

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Squarepoint's OSIR Position: Q2 2019 in Review

Squarepoint sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 29,620 shares — an estimated $563K sold.

Squarepoint first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $563K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Squarepoint reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Squarepoint sold 29,620 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $563K.
  • Squarepoint first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Squarepoint's Osiris Therapeutics, Inc. Common Stock position peaked at $563K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Squarepoint's 13F filing for Q2 2019, filed 14 Aug 2019.